Ligand validation:5AKP

BLA: BILIVERDINE IX ALPHA

BLA is a Ligand Of Interest in 5AKP designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5AKP_BLA_A_900	1%	7%	0.653	0.792	3.07	1.92	12	12	15	0	100%	0.75
5AKP_BLA_B_900	1%	12%	0.61	0.682	2.99	1.31	8	7	14	0	100%	0.75
7L5A_BLA_A_900	54%	6%	0.192	0.957	3.61	1.66	21	13	2	0	100%	1
7L59_BLA_A_900	52%	6%	0.202	0.963	3.71	1.64	19	14	2	0	100%	1
6PL0_BLA_A_900	12%	17%	0.343	0.877	1.81	2.01	10	15	4	0	100%	1
5UYR_BLA_A_900	2%	50%	0.546	0.826	1.01	0.91	3	3	14	0	100%	1
5B4J_BLA_A_301	98%	19%	0.055	0.981	2	1.61	10	5	0	0	100%	1
5VIQ_BLA_A_401	95%	5%	0.067	0.97	2.99	2.59	16	21	1	0	100%	1
3NB8_BLA_A_249	95%	10%	0.068	0.97	2.56	1.99	11	12	0	0	100%	1
7E2S_BLA_A_301	94%	10%	0.063	0.962	2.91	1.56	18	7	0	0	100%	1
5VIK_BLA_A_401	94%	8%	0.068	0.967	2.82	2.1	14	17	3	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.